A trivial explanation of this data is that the grade I-III tumor samples, as a result of the diffuse nature of the tumors, contain a larger percentage of normal cells than the grade IV tumors, and that the admixture of normal cells expressing high levels of PKM1 and tumor cells expressing high levels of PKM2 results in a grade I-III glioma sample that appears as a whole to have a lower level of PKM2 expression than its truly tumorigenic components. Here, PKM is linked to glioma.